Evidence map›Paper›PMID 25479425›Full record

ArticlePloS one2014

Hyperosmolarity invokes distinct anti-inflammatory mechanisms in pulmonary epithelial cells: evidence from signaling and transcription layers.

Franklin L Wright, Fabia Gamboni, Ernest E Moore, Trevor L Nydam, Sanchayita Mitra, Christopher C Silliman, Anirban Banerjee

Registry-linked trialOpen access · goldAbstract read
In one paragraph

Article in PloS one, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT04465604 (HYPERTONIC SALINE COATED FACE MASK FOR REDUCING RESPIRATORY SYMPTOM SEVERITY IN PATIENTS WITH COVID-19), which is not on this map. Cited by 17 papers.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed
1.9field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT04465604 naunknown statusnot on this mapstarted 2021, after this paper: background citation

Hypertonic saline coated face mask for reducing respiratory symptom severity in patients with covid-19

TypeinterventionalSponsorKing Faisal Specialist Hospital & Research CenterRan2021 to 2022Enrolled50ConditionsCOVID-19ArmsWearing surgical face mask sprayed with hypertonic saline
3 · Its place in the literature

Who cites it

17 citing papers in PubMed, 28 citations in OpenAlex.

  1. Trial
  2. Review
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Review
  15. Article
  16. Article
  17. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 1 country.

Franklin L WrightDepartment of Surgery/Trauma Research Center, University of Colorado Denver, Aurora, Colorado, United States of America.
Fabia GamboniDepartment of Surgery/Trauma Research Center, University of Colorado Denver, Aurora, Colorado, United States of America.
Ernest E MooreDepartment of Surgery, Denver Health Medical Center, Denver, Colorado, United States of America.
Trevor L NydamDepartment of Surgery/Trauma Research Center, University of Colorado Denver, Aurora, Colorado, United States of America.
Sanchayita MitraDepartment of Surgery/Trauma Research Center, University of Colorado Denver, Aurora, Colorado, United States of America.
Christopher C SillimanDepartment of Pediatrics, University of Colorado Denver, Aurora, Colorado, United States of America.
Anirban BanerjeeDepartment of Surgery/Trauma Research Center, University of Colorado Denver, Aurora, Colorado, United States of America.
University of Colorado Denver · USDenver Health Medical Center · US

Funding

Trauma Reprograms CellsP50GM049222 · NIGMS · UNIVERSITY OF COLORADO DENVER · PI BANERJEE, ANIRBAN · 1993 to 2017
$26.1M
Mechanisms of Trauma-Induced CoagulopathyT32GM008315 · NIGMS · UNIVERSITY OF COLORADO DENVER · PI Mitchell Cohen, ELIZABETH J. KOVACS · 1991 to 2026
$7.1M
NIGMS NIH HHS P50 GM049222NIGMS NIH HHS T32 GM008315
6 · The paper itself

Abstract

Hypertonic saline (HTS) has been used intravenously to reduce organ dysfunction following injury and as an inhaled therapy for cystic fibrosis lung disease. The role and mechanism of HTS inhibition was explored in the TNFα and IL-1β stimulation of pulmonary epithelial cells. Hyperosmolar (HOsm) media (400 mOsm) inhibited the production of select cytokines stimulated by TNFα and IL-1β at the level of mRNA translation, synthesis and release. In TNFα stimulated A549 cells, HOsm media inhibited I-κBα phosphorylation, NF-κB translocation into the nucleus and NF-κB nuclear binding. In IL-1β stimulated cells HOsm inhibited I-κBα phosphorylation without affecting NF-κB translocation or nuclear binding. Incubation in HOsm conditions inhibited both TNFα and IL-1β stimulated nuclear localization of interferon response factor 1 (IRF-1). Additional transcription factors such as AP-1, Erk-1/2, JNK and STAT-1 were unaffected by HOsm. HTS and sorbitol supplemented media produced comparable outcomes in all experiments, indicating that the effects of HTS were mediated by osmolarity, not by sodium. While not affecting MAPK modules discernibly in A549 cells, both HOsm conditions inhibit IRF-1 against TNFα or IL-1β, but inhibit p65 NF-kB translocation only against TNFα but not IL-1β. Thus, anti-inflammatory mechanisms of HTS/HOsm appear to disrupt cytokine signals at distinct intracellular steps.

Indexed as

Transcription, GeneticCell LineEpithelial CellsHumansInflammationInterleukin-1betaLungNF-kappa BPhosphorylationSaline Solution, HypertonicSignal TransductionTranscription Factor RelATumor Necrosis Factor-alphaInterleukin-1betaNF-kappa BSaline Solution, HypertonicTranscription Factor RelATumor Necrosis Factor-alpha

Identifiers

PMID25479425
PMCPMC4257597
OpenAlexW1997095998

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.